Journal article · 2020 · Open access

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

Ravindra K. Gupta, Dimitra Peppa, Alison L. Hill, Cristina Gálvez, María Salgado, Matthew J. Pace, Laura E. McCoy, Sarah A. Griffith, John Patrick Thornhill, Aljawharah Alrubayyi, Laura E. P. Huyveneers, Eleni Nastouli and 8 more

The Lancet HIV, 7(5), e340–e347 · Published 10 March 2020 · DOI 10.1016/s2352-3018(20)30069-2

Open PDFView at the publisherCite this paper

In brief

“Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report” is a 2020 journal article by Ravindra K. Gupta and 19 co-authors, published in The Lancet HIV. OpenAlex counts 264 citations as of 19 November 2026, which puts it in the top 1% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at The Lancet HIV.

Citations
264
Most cited in
2023 (46)
Field-weighted impact
13.63
References
31
Authors
20

Abstract

Background The London patient (participant 36 in the IciStem cohort) underwent allogeneic stem-cell transplantation with cells that did not express CCR5 ( CCR5 Δ32/Δ32); remission was reported at 18 months after analytical treatment interruption (ATI). Here, we present longer term data for this patient (up to 30 months after ATI), including sampling from diverse HIV-1 reservoir sites. Methods We used ultrasensitive viral load assays of plasma, semen, and cerebrospinal fluid (CSF) samples to detect HIV-1 RNA. In gut biopsy samples and lymph-node tissue, cell-copy number and total HIV-1 DNA levels were quantified in multiple replicates, using droplet digital PCR (ddPCR) and quantitative real-time PCR. We also analysed the presence of intact proviral DNA using multiplex ddPCR targeting the packaging signal (ψ) and envelope ( env ). We did intracellular cytokine staining to measure HIV-1-specific T-cell responses. We used low-sensitive and low-avidity antibody assays to measure the humoral response to HIV-1. We predicted the probability of rebound using a mathematical model and inference approach. Findings HIV-1 viral load in plasma remained undetectable in the London patient up to 30 months (last tested on March 4, 2020), using an assay with a detection limit of 1 copy per mL. The patient's CD4 count was 430 cells per μL (23·5% of total T cells) at 28 months. A very low-level positive signal for HIV-1 DNA was recorded in peripheral CD4 memory cells at 28 months. The viral load in semen was undetectable in both plasma (lower limit of detection [LLD] <12 copies per mL) and cells (LLD 10 copies per 10 6 cells) at 21 months. CSF was within normal parameters at 25 months, with HIV-1 RNA below the detection limit (LLD 1 copy per mL). HIV-1 DNA by ddPCR was negative in rectum, caecum, and sigmoid colon and terminal ileum tissue samples at 22 months. Lymph-node tissue from axilla was positive for the long-terminal repeat (33 copies per 10 6 cells) and env (26·1 copies per 10 6 cells), negative for ψ and integrase, and negative by the intact proviral DNA assay, at 27 months. HIV-1-specific CD4 and CD8 T-cell responses have remained absent at 27 months. Low-avidity Env antibodies have continued to decline. Mathematical modelling suggests that the probability of remission for life (cure) is 98% in the context of 80% donor chimerism in total HIV target cells and greater than 99% probability of remission for life with 90% donor chimerism. Interpretation The London patient has been in HIV-1 remission for 30 months with no detectable replication-competent virus in blood, CSF…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gupta, R. K., Peppa, D., Hill, A. L., Gálvez, C., Salgado, M., Pace, M. J., McCoy, L. E., Griffith, S. A., Thornhill, J. P., Alrubayyi, A., Huyveneers, L. E. P., Nastouli, E., Grant, P. R., Edwards, S., Innes, A. J., Frater, J., Nijhuis, M., Wensing, A. M. J., Martínez‐Picado, J., & Olavarría, E. (2020). Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. The Lancet HIV, 7(5), e340–e347. https://doi.org/10.1016/s2352-3018(20)30069-2

MLA 9

Gupta, Ravindra K., et al. “Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.” The Lancet HIV, vol. 7, no. 5, 2020, pp. e340–e347. https://doi.org/10.1016/s2352-3018(20)30069-2.

Chicago

Gupta, Ravindra K., Dimitra Peppa, Alison L. Hill, Cristina Gálvez, María Salgado, Matthew J. Pace, Laura E. McCoy, et al. 2020. “Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.” The Lancet HIV 7 (5): e340–e347. https://doi.org/10.1016/s2352-3018(20)30069-2.

Harvard

Gupta, R. K. et al. (2020) ‘Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report’, The Lancet HIV, 7(5), pp. e340–e347. doi:10.1016/s2352-3018(20)30069-2.

IEEE

R. K. Gupta et al., “Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report,” The Lancet HIV, vol. 7, no. 5, pp. e340–e347, 2020, doi: 10.1016/s2352-3018(20)30069-2.

BibTeX

@article{gupta2020evidence,
  title     = {{Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report}},
  author    = {Gupta, Ravindra K. and Peppa, Dimitra and Hill, Alison L. and Gálvez, Cristina and Salgado, María and Pace, Matthew J. and McCoy, Laura E. and Griffith, Sarah A. and Thornhill, John Patrick and Alrubayyi, Aljawharah and Huyveneers, Laura E. P. and Nastouli, Eleni and Grant, Paul R. and Edwards, Simon and Innes, Andrew J. and Frater, John and Nijhuis, Monique and Wensing, A. M. J. and Martínez‐Picado, Javier and Olavarría, Eduardo},
  journal   = {The Lancet HIV},
  year      = {2020},
  volume    = {7},
  number    = {5},
  pages     = {e340--e347},
  doi       = {10.1016/s2352-3018(20)30069-2},
  url       = {https://doi.org/10.1016/s2352-3018(20)30069-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20203232
20214545
20223838
20234646
20244646
20253737
20262020

Its field-weighted citation impact is 13.63: it has been cited 13.63 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV-1 cure
  • allogeneic hematopoietic stem cell transplantation
  • analytical treatment interruption
  • HIV-1 reservoir
  • long-term viral suppression
  • HIV-1-specific T cell responses
  • humoral immune response
  • mathematical model

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Gupta, R. K., Peppa, D., Hill, A. L., Gálvez, C., Salgado, M., Pace, M. J., McCoy, L. E., Griffith, S. A., Thornhill, J. P., Alrubayyi, A., Huyveneers, L. E. P., Nastouli, E., Grant, P. R., Edwards, S., Innes, A. J., Frater, J., Nijhuis, M., Wensing, A. M. J., Martínez‐Picado, J., & Olavarría, E. (2020). Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. The Lancet HIV, 7(5), e340–e347. https://doi.org/10.1016/s2352-3018(20)30069-2

How many times has this paper been cited?

264 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Lancet HIV: sign in and open the PDF from this page.

Who wrote this paper?

Ravindra K. Gupta, Dimitra Peppa, Alison L. Hill, Cristina Gálvez, María Salgado, Matthew J. Pace, Laura E. McCoy, Sarah A. Griffith, John Patrick Thornhill, Aljawharah Alrubayyi, Laura E. P. Huyveneers, Eleni Nastouli and 8 more.

What is the DOI of this paper?

10.1016/s2352-3018(20)30069-2, permanently at https://doi.org/10.1016/s2352-3018(20)30069-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.